Pub Date : 2024-12-01DOI: 10.14423/SMJ.0000000000001760
Andrew Sephien, Marc Lozano, Sean-Patrick Prince, Denisse Camille Dayto, Caroline Minton, Ambuj Kumar, Nishant Nerella, Guarav Shah
Objectives: Current guidelines recommend dexamethasone 6 mg/day for up to 10 days in patients with severe coronavirus disease 2019 (COVID-19) requiring supplemental oxygenation or mechanical ventilation. The practice has significant variation, however, and dexamethasone has been used for >10 days for many patients with severe COVID-19. The aim of this study was to assess the benefits and risks associated with standard versus extended use of dexamethasone in patients with severe COVID-19.
Methods: A multicenter retrospective cohort study was conducted from January 2021 to December 2021. All of the consecutive patients with severe COVID-19 receiving 6 mg/day dexamethasone were eligible for inclusion. The primary outcome was the incidence of in-hospital mortality for patients treated with dexamethasone 6 mg/day for the standard duration of 10 days versus an extended duration of >10 days.
Results: A total of 1294 patients met the inclusion criteria: 803 received the standard duration of dexamethasone and 491 received the extended duration. The incidence of in-hospital mortality was significantly higher (P = 0.003) in the extended duration group (36.5%) compared with the standard duration group (28.5%), with no significant difference in in-hospital major adverse cardiac events (16.1% for extended vs 13.2% for the standard duration; P = 0.15).
Conclusions: The results show that extended duration of dexamethasone compared with standard duration is associated with a significant increase in in-hospital mortality in patients with severe COVID-19. These findings need to be confirmed in well-designed and performed randomized controlled trials.
{"title":"Comparison of Standard and Extended Dexamethasone Duration on Mortality in Patients with Severe COVID-19.","authors":"Andrew Sephien, Marc Lozano, Sean-Patrick Prince, Denisse Camille Dayto, Caroline Minton, Ambuj Kumar, Nishant Nerella, Guarav Shah","doi":"10.14423/SMJ.0000000000001760","DOIUrl":"10.14423/SMJ.0000000000001760","url":null,"abstract":"<p><strong>Objectives: </strong>Current guidelines recommend dexamethasone 6 mg/day for up to 10 days in patients with severe coronavirus disease 2019 (COVID-19) requiring supplemental oxygenation or mechanical ventilation. The practice has significant variation, however, and dexamethasone has been used for >10 days for many patients with severe COVID-19. The aim of this study was to assess the benefits and risks associated with standard versus extended use of dexamethasone in patients with severe COVID-19.</p><p><strong>Methods: </strong>A multicenter retrospective cohort study was conducted from January 2021 to December 2021. All of the consecutive patients with severe COVID-19 receiving 6 mg/day dexamethasone were eligible for inclusion. The primary outcome was the incidence of in-hospital mortality for patients treated with dexamethasone 6 mg/day for the standard duration of 10 days versus an extended duration of >10 days.</p><p><strong>Results: </strong>A total of 1294 patients met the inclusion criteria: 803 received the standard duration of dexamethasone and 491 received the extended duration. The incidence of in-hospital mortality was significantly higher (<i>P =</i> 0.003) in the extended duration group (36.5%) compared with the standard duration group (28.5%), with no significant difference in in-hospital major adverse cardiac events (16.1% for extended vs 13.2% for the standard duration; <i>P</i> = 0.15).</p><p><strong>Conclusions: </strong>The results show that extended duration of dexamethasone compared with standard duration is associated with a significant increase in in-hospital mortality in patients with severe COVID-19. These findings need to be confirmed in well-designed and performed randomized controlled trials.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 12","pages":"701-704"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.14423/SMJ.0000000000001762
Olivia Moumne, Lori M Gawron, Kathryn E Storck, Jessica N Sanders, David K Turok, Misha Pangasa
Objectives: The level of knowledge about contraceptives overall is low in the United States. This qualitative study adds to the literature that explores gendered differences in contraceptive knowledge. Specifically, we examined knowledge regarding different contraceptive methods, directions on use, mechanism of action, efficacy, and adverse effects. We also looked at men's perspectives on their partner's knowledge.
Methods: Participants were interviewed at a Planned Parenthood Association of Utah clinic. They were asked about contraception knowledge, attitudes, and male involvement in contraceptive decision making. In this secondary analysis, we reanalyzed codes that were previously identified under primary analysis for specific content about contraceptive knowledge and differences by sex.
Results: We found an overall low level of knowledge about contraceptives, particularly in men as compared with women. Men often overestimate their female partners' knowledge. Men were more likely to understand how to use methods that require their direct participation. Although women's contraceptive knowledge was better than that of the male participants, it was still poor overall.
Conclusions: A low level of knowledge about contraceptives is associated with increased rates of unintended pregnancy. This study demonstrates a need for improved education about contraception. Given the impact of male opinion in contraceptive use, efforts to increase their knowledge could be important interventions to increase contraceptive uptake.
{"title":"Qualitative Exploration of Contraceptive Knowledge in Men and Women.","authors":"Olivia Moumne, Lori M Gawron, Kathryn E Storck, Jessica N Sanders, David K Turok, Misha Pangasa","doi":"10.14423/SMJ.0000000000001762","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001762","url":null,"abstract":"<p><strong>Objectives: </strong>The level of knowledge about contraceptives overall is low in the United States. This qualitative study adds to the literature that explores gendered differences in contraceptive knowledge. Specifically, we examined knowledge regarding different contraceptive methods, directions on use, mechanism of action, efficacy, and adverse effects. We also looked at men's perspectives on their partner's knowledge.</p><p><strong>Methods: </strong>Participants were interviewed at a Planned Parenthood Association of Utah clinic. They were asked about contraception knowledge, attitudes, and male involvement in contraceptive decision making. In this secondary analysis, we reanalyzed codes that were previously identified under primary analysis for specific content about contraceptive knowledge and differences by sex.</p><p><strong>Results: </strong>We found an overall low level of knowledge about contraceptives, particularly in men as compared with women. Men often overestimate their female partners' knowledge. Men were more likely to understand how to use methods that require their direct participation. Although women's contraceptive knowledge was better than that of the male participants, it was still poor overall.</p><p><strong>Conclusions: </strong>A low level of knowledge about contraceptives is associated with increased rates of unintended pregnancy. This study demonstrates a need for improved education about contraception. Given the impact of male opinion in contraceptive use, efforts to increase their knowledge could be important interventions to increase contraceptive uptake.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 12","pages":"681-685"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142771978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001755
Anup Das, Ethan Molitch-Hou, Shannon K Martin
Objectives: As hospital medicine (HM) has grown as a specialty, it has been paralleled by an increase in HM fellowship training programs. Limited data are available surrounding clinical exposure for HM fellows. Using data from a large academic medical center with a long-standing HM fellowship program, we reviewed the types of clinical shifts and distribution of shift data completed by HM fellows from 2013 to 2023.
Methods: We performed a retrospective analysis of clinical shifts available from an internal Web-based scheduling program. Shifts performed by HM fellows were downloaded from May 2013 through February 2023. We characterized clinical service shifts as day coverage, off-hour coverage, teaching services, or jeopardy. We calculated summary statistics of the number of shifts worked by HM fellows per year.
Results: During a period of 10 years, 22 HM fellows completed 4430 shifts, with a mean total of 197.3 shifts during fellowship (standard deviation 56.7 shifts). Most of the shifts completed by HM fellows were off-hours shifts (51.0%, n = 2214), with less exposure to daytime shifts (n = 1285, 29.6%) and the least exposure to teaching shifts (n = 390, 9.0%).
Conclusions: HM fellows spend the majority of their clinical time on off-hours shifts, which does not reflect the clinical practice of an academic hospitalist. The least amount of time was spent attending on traditional teaching services. Because HM fellowships are designed to prepare HM fellows for careers as academic hospitalists, more work is necessary to determine how best to optimize and standardize clinical exposure while maintaining adequate time for opportunities to engage in academic development.
{"title":"Clinical Shift Distribution in Academic Hospital Medicine Fellowship across 10 Years.","authors":"Anup Das, Ethan Molitch-Hou, Shannon K Martin","doi":"10.14423/SMJ.0000000000001755","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001755","url":null,"abstract":"<p><strong>Objectives: </strong>As hospital medicine (HM) has grown as a specialty, it has been paralleled by an increase in HM fellowship training programs. Limited data are available surrounding clinical exposure for HM fellows. Using data from a large academic medical center with a long-standing HM fellowship program, we reviewed the types of clinical shifts and distribution of shift data completed by HM fellows from 2013 to 2023.</p><p><strong>Methods: </strong>We performed a retrospective analysis of clinical shifts available from an internal Web-based scheduling program. Shifts performed by HM fellows were downloaded from May 2013 through February 2023. We characterized clinical service shifts as day coverage, off-hour coverage, teaching services, or jeopardy. We calculated summary statistics of the number of shifts worked by HM fellows per year.</p><p><strong>Results: </strong>During a period of 10 years, 22 HM fellows completed 4430 shifts, with a mean total of 197.3 shifts during fellowship (standard deviation 56.7 shifts). Most of the shifts completed by HM fellows were off-hours shifts (51.0%, n = 2214), with less exposure to daytime shifts (n = 1285, 29.6%) and the least exposure to teaching shifts (n = 390, 9.0%).</p><p><strong>Conclusions: </strong>HM fellows spend the majority of their clinical time on off-hours shifts, which does not reflect the clinical practice of an academic hospitalist. The least amount of time was spent attending on traditional teaching services. Because HM fellowships are designed to prepare HM fellows for careers as academic hospitalists, more work is necessary to determine how best to optimize and standardize clinical exposure while maintaining adequate time for opportunities to engage in academic development.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"674-677"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Frail patients are at greater risk of experiencing adverse clinical outcomes in any critical illness due to decreased physiologic reserves, greater susceptibility to the adverse effects of treatment, and greater needs for intensive care. In this study, we sought to assess the prevalence of frailty and associated adverse in-hospital outcomes among coronavirus disease 2019 (COVID-19) hospitalizations using the 2020 California State Inpatient Database (SID).
Methods: For this study, we conducted a retrospective analysis of data from all COVID-19 hospital patients aged 18 years and older. We identified hospitalizations that were at high risk of frailty using the Hospital Frailty Risk Score. The primary outcome of our study was in-hospital mortality, and the secondary outcomes were prolonged length of stay, vasopressor use, mechanical ventilation, and intensive care unit admission.
Results: The prevalence of frailty was 44.3% among COVID-19 hospitalizations. Using propensity score matching analysis, we found that the odds of mortality (odds ratio [OR] 4.54, 95% confidence interval [CI] 4.28-4.82), prolonged length of stay (OR 2.81, 95% CI 2.70-2.90), vasopressor use (OR 8.65, 95% CI 7.45-10.03), mechanical ventilation (OR 6.90, 95% CI 6.47-7.35), and intensive care unit admission (OR 7.17, 95% CI 6.71-7.66) were significantly higher among the group of frail patients.
Conclusion: Our findings show that frailty could be used for assessing and risk stratifying patients for improved hospital outcomes.
目的:由于生理储备下降、更容易受到治疗的不良影响以及更需要重症监护,体弱患者在任何危重疾病中出现不良临床结果的风险都更大。在这项研究中,我们试图利用 2020 年加利福尼亚州住院病人数据库(SID)评估 2019 年冠状病毒病(COVID-19)住院病人中体弱的患病率和相关的院内不良预后:在这项研究中,我们对所有 18 岁及以上的 COVID-19 住院患者的数据进行了回顾性分析。我们使用医院虚弱风险评分(Hospital Frailty Risk Score)确定了虚弱高风险住院患者。研究的主要结果是院内死亡率,次要结果是住院时间延长、使用血管加压素、机械通气和入住重症监护室:结果:在 COVID-19 住院患者中,体弱患病率为 44.3%。通过倾向得分匹配分析,我们发现死亡率(几率比 [OR] 4.54,95% 置信区间 [CI] 4.28-4.82)、住院时间延长(OR 2.81,95% CI 2.70-2.90)、使用血管加压器(OR 8.65,95% CI 7.45-10.03)、机械通气(OR 6.90,95% CI 6.47-7.35)和入住重症监护室(OR 7.17,95% CI 6.71-7.66)在体弱患者组中明显较高:我们的研究结果表明,体弱可用于对患者进行评估和风险分层,以改善住院效果。
{"title":"Impact of Frailty on COVID-19 Hospitalizations: Results from the California State Inpatient Database.","authors":"Muni Rubens, Anshul Saxena, Venkataraghavan Ramamoorthy, Sandeep Appunni, Md Ashfaq Ahmed, Zhenwei Zhang, Yanjia Zhang, Rehan Sha, Samer Fahmy","doi":"10.14423/SMJ.0000000000001754","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001754","url":null,"abstract":"<p><strong>Objectives: </strong>Frail patients are at greater risk of experiencing adverse clinical outcomes in any critical illness due to decreased physiologic reserves, greater susceptibility to the adverse effects of treatment, and greater needs for intensive care. In this study, we sought to assess the prevalence of frailty and associated adverse in-hospital outcomes among coronavirus disease 2019 (COVID-19) hospitalizations using the 2020 California State Inpatient Database (SID).</p><p><strong>Methods: </strong>For this study, we conducted a retrospective analysis of data from all COVID-19 hospital patients aged 18 years and older. We identified hospitalizations that were at high risk of frailty using the Hospital Frailty Risk Score. The primary outcome of our study was in-hospital mortality, and the secondary outcomes were prolonged length of stay, vasopressor use, mechanical ventilation, and intensive care unit admission.</p><p><strong>Results: </strong>The prevalence of frailty was 44.3% among COVID-19 hospitalizations. Using propensity score matching analysis, we found that the odds of mortality (odds ratio [OR] 4.54, 95% confidence interval [CI] 4.28-4.82), prolonged length of stay (OR 2.81, 95% CI 2.70-2.90), vasopressor use (OR 8.65, 95% CI 7.45-10.03), mechanical ventilation (OR 6.90, 95% CI 6.47-7.35), and intensive care unit admission (OR 7.17, 95% CI 6.71-7.66) were significantly higher among the group of frail patients.</p><p><strong>Conclusion: </strong>Our findings show that frailty could be used for assessing and risk stratifying patients for improved hospital outcomes.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"646-650"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001753
Rebecca C Gerrity, Melissa Parkinson, Rachel Strength, Chinelo N Animalu, Nathan Davidson, Christian J Fuchs, Christopher D Jackson, Nathan A Summers
Objectives: During the course of the coronavirus disease 2019 (COVID-19) pandemic, numerous comorbidities were identified as risk factors for increased morbidity and mortality. Few studies have examined human immunodeficiency virus (HIV) and COVID-19 co-infection and the impact of HIV on COVID-19 outcomes. In this study, we compared outcomes of people living with HIV with COVID-19 with a control group to examine outcomes.
Methods: We identified 45 people living with HIV admitted with COVID-19 to one of three large healthcare systems in Memphis, Tennessee, between March 1 and October 31, 2020. We matched the people living with HIV in a 1:1 fashion to a control group of COVID-19-positive patients without a recorded history of HIV and compared clinical outcomes. Nine pairs were not able to be optimally matched, so a sensitivity analysis was completed by repeating the same analyses in the primary analysis while excluding the nine mismatched pairs.
Results: Patients did not differ significantly in demographic variables due to the matching algorithm, and there was no significant difference in measured outcomes between people living with HIV and controls. A CD4 count of <200 cells per microliter was not significantly associated with increased morbidity or mortality. Controlling for HIV status, an elevated Charlson Comorbidity Index score of >3 was associated with increased intubation (P = 0.02), vasopressor use (odds ratio [OR] 4.81, P = 0.04), intensive care unit level of care (OR 4.37, P = 0.007), mortality (OR 7.14, P = 0.02), and length of overall hospital stay in days (P = 0.004).
Conclusions: We found no difference in outcomes of people living with HIV in comparison to matched controls based on HIV status but found that an increased Charlson Comorbidity Index score led to increased morbidity and mortality regardless of HIV status.
{"title":"Effect of HIV Status and Charlson Comorbidity Index on COVID-19 Clinical Outcomes in a Case-Control Study.","authors":"Rebecca C Gerrity, Melissa Parkinson, Rachel Strength, Chinelo N Animalu, Nathan Davidson, Christian J Fuchs, Christopher D Jackson, Nathan A Summers","doi":"10.14423/SMJ.0000000000001753","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001753","url":null,"abstract":"<p><strong>Objectives: </strong>During the course of the coronavirus disease 2019 (COVID-19) pandemic, numerous comorbidities were identified as risk factors for increased morbidity and mortality. Few studies have examined human immunodeficiency virus (HIV) and COVID-19 co-infection and the impact of HIV on COVID-19 outcomes. In this study, we compared outcomes of people living with HIV with COVID-19 with a control group to examine outcomes.</p><p><strong>Methods: </strong>We identified 45 people living with HIV admitted with COVID-19 to one of three large healthcare systems in Memphis, Tennessee, between March 1 and October 31, 2020. We matched the people living with HIV in a 1:1 fashion to a control group of COVID-19-positive patients without a recorded history of HIV and compared clinical outcomes. Nine pairs were not able to be optimally matched, so a sensitivity analysis was completed by repeating the same analyses in the primary analysis while excluding the nine mismatched pairs.</p><p><strong>Results: </strong>Patients did not differ significantly in demographic variables due to the matching algorithm, and there was no significant difference in measured outcomes between people living with HIV and controls. A CD4 count of <200 cells per microliter was not significantly associated with increased morbidity or mortality. Controlling for HIV status, an elevated Charlson Comorbidity Index score of >3 was associated with increased intubation (<i>P</i> = 0.02), vasopressor use (odds ratio [OR] 4.81, <i>P</i> = 0.04), intensive care unit level of care (OR 4.37, <i>P</i> = 0.007), mortality (OR 7.14, <i>P</i> = 0.02), and length of overall hospital stay in days (<i>P</i> = 0.004).</p><p><strong>Conclusions: </strong>We found no difference in outcomes of people living with HIV in comparison to matched controls based on HIV status but found that an increased Charlson Comorbidity Index score led to increased morbidity and mortality regardless of HIV status.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"651-656"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001747
Sujeeth Shanmugam, Steven R Feldman
{"title":"User-Friendly Medication Packaging: The Birth Control Pill Story.","authors":"Sujeeth Shanmugam, Steven R Feldman","doi":"10.14423/SMJ.0000000000001747","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001747","url":null,"abstract":"","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"669"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001749
Greyson Fox Tran, Matthew Magee, Rafik Sadik Gendi, Buckley McCall, Jaron Pettis, Donald J DiPette
With the number of medical school applicants more than doubling during the past 30 years, there has been an increased need to mentor premedical undergraduate students. The Vertically Integrated Training Program at the University of South Carolina School of Medicine, Columbia, was created to provide direct mentoring for college students interested in a career as a physician. Online surveys were distributed at the beginning and end of the Fall 2023 semester to gain insight into the success of the program's events from the undergraduate perspective. Data suggest a trend toward positive change in terms of increased confidence of undergraduate students regarding the process of applying to and finding success in medical school. This article reviews the development of the Vertically Integrated Training Program, evaluates the success of the program, and suggests next steps for the organization.
{"title":"Advancement of a Vertically Integrated Training Program (VITP): Introspective Assessment and Expansion.","authors":"Greyson Fox Tran, Matthew Magee, Rafik Sadik Gendi, Buckley McCall, Jaron Pettis, Donald J DiPette","doi":"10.14423/SMJ.0000000000001749","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001749","url":null,"abstract":"<p><p>With the number of medical school applicants more than doubling during the past 30 years, there has been an increased need to mentor premedical undergraduate students. The Vertically Integrated Training Program at the University of South Carolina School of Medicine, Columbia, was created to provide direct mentoring for college students interested in a career as a physician. Online surveys were distributed at the beginning and end of the Fall 2023 semester to gain insight into the success of the program's events from the undergraduate perspective. Data suggest a trend toward positive change in terms of increased confidence of undergraduate students regarding the process of applying to and finding success in medical school. This article reviews the development of the Vertically Integrated Training Program, evaluates the success of the program, and suggests next steps for the organization.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"670-673"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001751
Sarah MacCarthy, Austin H Johnson, J Mac DeLay, Mallie Froehlich, Chase Harless, Marc N Elliott
Objectives: There are no statewide statistics regarding the health of lesbian, gay, bisexual, transgender, and queer (LGBTQ+) Alabamians. To fill this gap, we used data collected by the Southern Equality Research and Policy Center to compare Alabama with other southern US states regarding the health and well-being of LGBTQ+ people.
Methods: We tested for unadjusted differences between Alabama and other southern states using χ2 tests for dichotomous outcomes and the Wilcoxon rank-sum test for ordinal outcomes. Multivariate logistic models predicted dichotomous outcomes from an Alabama indicator, a continuous rurality variable, and a racial and ethnic minority indicator to control for differences in rurality and racial and ethnic composition; multivariate linear regression was used to approximate the point estimate of adjusted differences.
Results: Alabama and other southern states had statistically similar and high levels of abuse, harassment, and poor mental and physical health. Alabamians lived in ZIP codes with somewhat higher rural-urban commuting area code rurality scores (AL 1.76; South 1.70; P = 0.036, where 1 is the most urban category). More than one-fourth of Alabama respondents reported experiencing self-harming behaviors; one-third reported suicidal ideation (33.1%); more than half reported anxiety disorders (57.6%); more than two-thirds reported being depressed (69.2%); and 25% to 75% experienced or feared emotional and physical abuse because of their identity. Multivariate adjusted results were generally similar to unadjusted results.
Conclusions: Alabama LGBTQ+ populations, who live in more rural settings than in most prior studies, experience markedly poor outcomes.
{"title":"LGBTQ+ Health Inequities in a Rural, Conservative Context: Alabama Compared with Other Southern States.","authors":"Sarah MacCarthy, Austin H Johnson, J Mac DeLay, Mallie Froehlich, Chase Harless, Marc N Elliott","doi":"10.14423/SMJ.0000000000001751","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001751","url":null,"abstract":"<p><strong>Objectives: </strong>There are no statewide statistics regarding the health of lesbian, gay, bisexual, transgender, and queer (LGBTQ+) Alabamians. To fill this gap, we used data collected by the Southern Equality Research and Policy Center to compare Alabama with other southern US states regarding the health and well-being of LGBTQ+ people.</p><p><strong>Methods: </strong>We tested for unadjusted differences between Alabama and other southern states using χ<sup>2</sup> tests for dichotomous outcomes and the Wilcoxon rank-sum test for ordinal outcomes. Multivariate logistic models predicted dichotomous outcomes from an Alabama indicator, a continuous rurality variable, and a racial and ethnic minority indicator to control for differences in rurality and racial and ethnic composition; multivariate linear regression was used to approximate the point estimate of adjusted differences.</p><p><strong>Results: </strong>Alabama and other southern states had statistically similar and high levels of abuse, harassment, and poor mental and physical health. Alabamians lived in ZIP codes with somewhat higher rural-urban commuting area code rurality scores (AL 1.76; South 1.70; <i>P</i> = 0.036, where 1 is the most urban category). More than one-fourth of Alabama respondents reported experiencing self-harming behaviors; one-third reported suicidal ideation (33.1%); more than half reported anxiety disorders (57.6%); more than two-thirds reported being depressed (69.2%); and 25% to 75% experienced or feared emotional and physical abuse because of their identity. Multivariate adjusted results were generally similar to unadjusted results.</p><p><strong>Conclusions: </strong>Alabama LGBTQ+ populations, who live in more rural settings than in most prior studies, experience markedly poor outcomes.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"634-639"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001756
Mark Mitchell, Richard Huynh, Chenhao Zhao, Lorri Reaves, Alva Weir, Lindsey Lands
Objectives: The reasons for and incidence of delay in screening colonoscopies during the coronavirus disease 2019 (COVID-19) pandemic are of major public health interest. The risks and reasons for delay likely vary between public and private institutions. This research sought to analyze data regarding the completion of screening colonoscopies after a positive fecal immunochemical test (FIT) before and during the COVID-19 pandemic and the reasons for a delay in obtaining these results at the Lt. Col. Luke Weathers, Jr. Veterans Affairs Medical Center. The goals were to evaluate the institutional resilience and analyze the problems associated with this major healthcare crisis.
Methods: This closed cohort study included all positive FITs from our local Veterans Affairs (VA) medical center from October 2019 to January 2020 and July 2020 to May 2021. A total of 115 VA patients with a positive FIT prepandemic and 157 VA patients with a positive FIT during the pandemic were included. Completion rates within 180 days were measured, and charts were reviewed to identify the reasons for lack of completion. Both community and local VA procedures for veterans were included. Univariate and multivariable analyses were applied to calculate odds ratios (ORs). The Pearson χ2 test was applied to calculate P values.
Results: VA patients' percentage of timely completion was lower pre-COVID-19 than it was during the pandemic, and the percentage of delayed completion was higher pre-COVID-19 than it was during the pandemic. Comparing patients who completed a colonoscopy with those who did not, increasing age had an OR of 0.947 (95% CI 0.920-0.975), and White race had an OR of 0.504 (95% CI 0.291-0.873). Evaluating delays in colonoscopy completion, VA colonoscopies versus referral to the community had an OR of 4.472 (95% CI 1.602-12.483), and pre-COVID-19 completion versus during COVID-19 had an OR of 4.663 (95% CI 1.727-12.594) with multivariable logistic regression.
Conclusions: There was a statistically significant increase in timely colonoscopy completion during the study period when compared with the pre-COVID-19 period. The completion rate was higher at the Lt. Col. Luke Weathers, Jr. VA Medical Center than a large population average in 2020, possibly related to community colonoscopies and an aggressive case management system. In addition, increasing age and White race were associated with decreased colonoscopy completion. Predictors of an increased delay in colonoscopy completion included a pre-COVID-19 positive FIT and colonoscopies performed within the VA rather than being referred to providers in the community. A common reason for delay in all of the groups was patients declining intervention and delay/lack of referral.
目的:在 2019 年冠状病毒病(COVID-19)大流行期间,结肠镜筛查延迟的原因和发生率是一个重大的公共卫生问题。公立和私立机构的风险和延迟原因可能各不相同。这项研究旨在分析在 COVID-19 大流行之前和期间,粪便免疫化学试验 (FIT) 呈阳性后完成结肠镜筛查的相关数据,以及在小卢克-韦瑟斯中校退伍军人事务医疗中心延迟获得这些结果的原因。退伍军人事务医疗中心延迟获得这些结果的原因。目的是评估机构的应变能力,并分析与这一重大医疗危机相关的问题:这项封闭式队列研究包括当地退伍军人事务(VA)医疗中心在 2019 年 10 月至 2020 年 1 月和 2020 年 7 月至 2021 年 5 月期间的所有 FIT 阳性病例。共有 115 名退伍军人在大流行前 FIT 阳性,157 名退伍军人在大流行期间 FIT 阳性。对 180 天内的完成率进行了测量,并对病历进行了审查,以确定未完成的原因。社区和当地退伍军人管理局的退伍军人程序都包括在内。采用单变量和多变量分析来计算几率比(OR)。采用 Pearson χ2 检验计算 P 值:结果:退伍军人患者及时完成结肠镜检查的比例在COVID-19之前低于大流行期间,而延迟完成结肠镜检查的比例在COVID-19之前高于大流行期间。将完成结肠镜检查的患者与未完成检查的患者进行比较,年龄增加的 OR 值为 0.947(95% CI 0.920-0.975),白种人的 OR 值为 0.504(95% CI 0.291-0.873)。通过多变量逻辑回归评估结肠镜检查完成时间的延迟情况,退伍军人结肠镜检查与社区转诊的OR值为4.472(95% CI 1.602-12.483),COVID-19前与COVID-19期间的OR值为4.663(95% CI 1.727-12.594):与 COVID-19 前相比,研究期间及时完成结肠镜检查的人数在统计学上有明显增加。Luke Weathers, Jr.中校退伍军人医疗中心的结肠镜检查完成率高于全国平均水平。退伍军人医疗中心的结肠镜检查完成率高于 2020 年大型人群的平均水平,这可能与社区结肠镜检查和积极的病例管理系统有关。此外,年龄的增长和白种人与结肠镜检查完成率的下降也有关系。结肠镜检查完成时间延迟增加的预测因素包括:COVID-19 前 FIT 阳性,以及在退伍军人事务部内进行结肠镜检查,而不是转诊给社区的医疗服务提供者。在所有组别中,延迟的一个共同原因是患者拒绝接受干预和延迟/缺乏转诊。
{"title":"A Cohort Study of Lt. Col. Luke J. Weathers VA Medical Center Patients with Positive FIT and Incomplete GI Evaluation during the COVID-19 Pandemic.","authors":"Mark Mitchell, Richard Huynh, Chenhao Zhao, Lorri Reaves, Alva Weir, Lindsey Lands","doi":"10.14423/SMJ.0000000000001756","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001756","url":null,"abstract":"<p><strong>Objectives: </strong>The reasons for and incidence of delay in screening colonoscopies during the coronavirus disease 2019 (COVID-19) pandemic are of major public health interest. The risks and reasons for delay likely vary between public and private institutions. This research sought to analyze data regarding the completion of screening colonoscopies after a positive fecal immunochemical test (FIT) before and during the COVID-19 pandemic and the reasons for a delay in obtaining these results at the Lt. Col. Luke Weathers, Jr. Veterans Affairs Medical Center. The goals were to evaluate the institutional resilience and analyze the problems associated with this major healthcare crisis.</p><p><strong>Methods: </strong>This closed cohort study included all positive FITs from our local Veterans Affairs (VA) medical center from October 2019 to January 2020 and July 2020 to May 2021. A total of 115 VA patients with a positive FIT prepandemic and 157 VA patients with a positive FIT during the pandemic were included. Completion rates within 180 days were measured, and charts were reviewed to identify the reasons for lack of completion. Both community and local VA procedures for veterans were included. Univariate and multivariable analyses were applied to calculate odds ratios (ORs). The Pearson χ<sup>2</sup> test was applied to calculate <i>P</i> values.</p><p><strong>Results: </strong>VA patients' percentage of timely completion was lower pre-COVID-19 than it was during the pandemic, and the percentage of delayed completion was higher pre-COVID-19 than it was during the pandemic. Comparing patients who completed a colonoscopy with those who did not, increasing age had an OR of 0.947 (95% CI 0.920-0.975), and White race had an OR of 0.504 (95% CI 0.291-0.873). Evaluating delays in colonoscopy completion, VA colonoscopies versus referral to the community had an OR of 4.472 (95% CI 1.602-12.483), and pre-COVID-19 completion versus during COVID-19 had an OR of 4.663 (95% CI 1.727-12.594) with multivariable logistic regression.</p><p><strong>Conclusions: </strong>There was a statistically significant increase in timely colonoscopy completion during the study period when compared with the pre-COVID-19 period. The completion rate was higher at the Lt. Col. Luke Weathers, Jr. VA Medical Center than a large population average in 2020, possibly related to community colonoscopies and an aggressive case management system. In addition, increasing age and White race were associated with decreased colonoscopy completion. Predictors of an increased delay in colonoscopy completion included a pre-COVID-19 positive FIT and colonoscopies performed within the VA rather than being referred to providers in the community. A common reason for delay in all of the groups was patients declining intervention and delay/lack of referral.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"657-661"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.14423/SMJ.0000000000001748
Carolina Gutierrez, Hannah Uhlig-Reche, Meaghan Mones, Michelle Rivera-Davila, Siddharth K Prakash, Melissa B Aldrich
Objective: Lymphedema commonly affects females with Turner syndrome (TS), although it may be underrecognized and untreated. The objective of this study was to better understand self-reported lymphedema prevalence, knowledge, and experience in TS.
Methods: A 24-question anonymous survey was distributed to females with TS or their caregivers at a TS community event, a TS adult comprehensive care center, and an associated pediatrics clinic. Survey questions assessed lymphedema awareness, diagnosis and history, treatments and compliance, and sequelae. Data were analyzed using descriptive statistics.
Results: Forty-one surveys were returned, with 51.2% (n = 21) completed by the patient (mean age 25.8 years), 26.8% by the caregiver (n = 11), 2.5% by both the patient and the caregiver (n = 1), and 19.5% (n = 8) with unmarked respondent type. Greater than 75% (n = 31) reported having heard of lymphedema, 26.8% (n = 11) reported discussing lymphedema with a healthcare provider, and 22% (n = 9) reported receiving a diagnosis of lymphedema. The median age at the time of lymphedema diagnosis was 2 years. The most commonly affected body sites were legs/feet, followed by arms/hands and neck/face; the majority of patients experienced lymphedema at multiple body sites. Lymphedema resolution was reported by half, with a median duration of 4.25 years. Only one-third of those with lymphedema reported receiving treatment for the condition, including use of specialized massage/manual lymphatic drainage and compression garments.
Conclusions: Identification of knowledge gaps and experience with lymphedema in TS can help with the development of targeted educational interventions. Greater awareness and understanding of this treatable condition in TS may contribute to improved health outcomes.
{"title":"Lymphedema Awareness and Experience in the Turner Syndrome Community.","authors":"Carolina Gutierrez, Hannah Uhlig-Reche, Meaghan Mones, Michelle Rivera-Davila, Siddharth K Prakash, Melissa B Aldrich","doi":"10.14423/SMJ.0000000000001748","DOIUrl":"https://doi.org/10.14423/SMJ.0000000000001748","url":null,"abstract":"<p><strong>Objective: </strong>Lymphedema commonly affects females with Turner syndrome (TS), although it may be underrecognized and untreated. The objective of this study was to better understand self-reported lymphedema prevalence, knowledge, and experience in TS.</p><p><strong>Methods: </strong>A 24-question anonymous survey was distributed to females with TS or their caregivers at a TS community event, a TS adult comprehensive care center, and an associated pediatrics clinic. Survey questions assessed lymphedema awareness, diagnosis and history, treatments and compliance, and sequelae. Data were analyzed using descriptive statistics.</p><p><strong>Results: </strong>Forty-one surveys were returned, with 51.2% (n = 21) completed by the patient (mean age 25.8 years), 26.8% by the caregiver (n = 11), 2.5% by both the patient and the caregiver (n = 1), and 19.5% (n = 8) with unmarked respondent type. Greater than 75% (n = 31) reported having heard of lymphedema, 26.8% (n = 11) reported discussing lymphedema with a healthcare provider, and 22% (n = 9) reported receiving a diagnosis of lymphedema. The median age at the time of lymphedema diagnosis was 2 years. The most commonly affected body sites were legs/feet, followed by arms/hands and neck/face; the majority of patients experienced lymphedema at multiple body sites. Lymphedema resolution was reported by half, with a median duration of 4.25 years. Only one-third of those with lymphedema reported receiving treatment for the condition, including use of specialized massage/manual lymphatic drainage and compression garments.</p><p><strong>Conclusions: </strong>Identification of knowledge gaps and experience with lymphedema in TS can help with the development of targeted educational interventions. Greater awareness and understanding of this treatable condition in TS may contribute to improved health outcomes.</p>","PeriodicalId":22043,"journal":{"name":"Southern Medical Journal","volume":"117 11","pages":"666-668"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}